Progress on the Study of PD-L1 Detection Methods in Non-small Cell Lung Cancer / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 40-44, 2019.
Article
en Zh
| WPRIM
| ID: wpr-772333
Biblioteca responsable:
WPRO
ABSTRACT
PD-1/PD-L1 inhibitors play an important role in the first-line and second-line treatment of non-small cell lung cancer (NSCLC), indicating a new treatment strategy of NSCLC. Completed clinical trials have shown that effective detection of PD-L1 expression is the key to the use of immunosuppressive agents. However, the gold standard for PD-L1 detection has still lacked. In recent years, immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA) have been continuously innovated, which accounts for good prospect in PD-L1 detection. The research progress of PD-L1 detection methods in NSCLC is summarized in this review.
.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Ensayo de Inmunoadsorción Enzimática
/
Inmunohistoquímica
/
Biomarcadores de Tumor
/
Reproducibilidad de los Resultados
/
Sensibilidad y Especificidad
/
Carcinoma de Pulmón de Células no Pequeñas
/
Diagnóstico
/
Antígeno B7-H1
/
Neoplasias Pulmonares
/
Metabolismo
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Lung Cancer
Año:
2019
Tipo del documento:
Article